Similar articles for PMID: 35443970

Year	Number of Results
2001	1
2002	1
2004	2
2005	3
2007	1
2008	4
2009	2
2010	5
2011	6
2012	5
2013	9
2014	8
2015	5
2016	5
2017	16
2018	16
2019	8
2020	11
2021	8
2022	3
2023	1

1

The individualisation of glycaemic targets in response to patient characteristics in type 2 diabetes: a scoping review.

Westall SJ, Narayanan RP, Watmough S, Irving G, Furlong N, McNulty S, Bujawansa S, Hardy K. Westall SJ, et al. Clin Med (Lond). 2022 May;22(3):257-265. doi: 10.7861/clinmed.2021-0764. Epub 2022 Apr 20. Clin Med (Lond). 2022. PMID: 35443970 Free PMC article. Review.

2

Position statement of the Australian Diabetes Society: individualisation of glycated haemoglobin targets for adults with diabetes mellitus.

Cheung NW, Conn JJ, d'Emden MC, Gunton JE, Jenkins AJ, Ross GP, Sinha AK, Andrikopoulos S, Colagiuri S, Twigg SM; Australian Diabetes Society. Cheung NW, et al. Med J Aust. 2009 Sep 21;191(6):339-44. doi: 10.5694/j.1326-5377.2009.tb02819.x. Med J Aust. 2009. PMID: 19769558

3

Optimal glycaemic control in elderly people with type 2 diabetes: what does the evidence say?

Mathur S, Zammitt NN, Frier BM. Mathur S, et al. Drug Saf. 2015 Jan;38(1):17-32. doi: 10.1007/s40264-014-0247-7. Drug Saf. 2015. PMID: 25481812 Review.

4

Individualisation of glycaemic management in older people with type 2 diabetes: a systematic review of clinical practice guidelines recommendations.

Christiaens A, Henrard S, Zerah L, Dalleur O, Bourdel-Marchasson I, Boland B. Christiaens A, et al. Age Ageing. 2021 Nov 10;50(6):1935-1942. doi: 10.1093/ageing/afab157. Age Ageing. 2021. PMID: 34379732

5

(Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.

Semlitsch T, Engler J, Siebenhofer A, Jeitler K, Berghold A, Horvath K. Semlitsch T, et al. Cochrane Database Syst Rev. 2020 Nov 9;11(11):CD005613. doi: 10.1002/14651858.CD005613.pub4. Cochrane Database Syst Rev. 2020. PMID: 33166419 Free PMC article.

6

What are the practical implications for treating diabetes in light of recent evidence? Updated recommendations from the Global Partnership for Effective Diabetes Management.

Bailey CJ, Blonde L, Del Prato S, Leiter LA, Nesto R; Global Partnership for Effective Diabetes Management. Bailey CJ, et al. Diab Vasc Dis Res. 2009 Oct;6(4):283-7. doi: 10.1177/1479164109341691. Diab Vasc Dis Res. 2009. PMID: 20368223 Free article.

7

Diabetes in the older patient: heterogeneity requires individualisation of therapeutic strategies.

Schernthaner G, Schernthaner-Reiter MH. Schernthaner G, et al. Diabetologia. 2018 Jul;61(7):1503-1516. doi: 10.1007/s00125-018-4547-9. Epub 2018 Feb 7. Diabetologia. 2018. PMID: 29417185 Free PMC article. Review.

8

Leveraging advances in diabetes technologies in primary care: a narrative review.

Bode B, King A, Russell-Jones D, Billings LK. Bode B, et al. Ann Med. 2021 Dec;53(1):805-816. doi: 10.1080/07853890.2021.1931427. Ann Med. 2021. PMID: 34184589 Free PMC article. Review.

9

Gender-based differences in glycaemic control and hypoglycaemia prevalence in patients with type 2 diabetes: results from patient-level pooled data of six randomized controlled trials.

Kautzky-Willer A, Kosi L, Lin J, Mihaljevic R. Kautzky-Willer A, et al. Diabetes Obes Metab. 2015 Jun;17(6):533-540. doi: 10.1111/dom.12449. Epub 2015 Mar 20. Diabetes Obes Metab. 2015. PMID: 25678212 Free PMC article.

10

The glycaemic sixer [glycaemic hexad].

Kalra S. Kalra S. J Pak Med Assoc. 2018 Oct;68(10):1541-1542. J Pak Med Assoc. 2018. PMID: 30317360 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed